本文選題：惡性腫瘤 + 發(fā)病�。� 參考：《現(xiàn)代預(yù)防醫(yī)學(xué)》2017年02期

【摘要】：對江蘇省鹽城市大豐區(qū)2008-2014年原發(fā)性惡性腫瘤新發(fā)病例進行隨訪,對惡性腫瘤患者的生存情況進行分析。方法選取大豐區(qū)腫瘤發(fā)病報告系統(tǒng)2008年1月1日-2014年12月31日確診登記原發(fā)性惡性腫瘤發(fā)病數(shù)據(jù)共15 734例患者,隨訪時間為2008年1月1日-2016年1月7日,使用壽命表(Survival)法分析累積生存率和存活時間中位數(shù),Wilcoxon法比較不同性別間的存活時間差異。結(jié)果 2008-2014年惡性腫瘤發(fā)病率為310.54/10萬,標(biāo)化率為179.96/10萬。5年累積生存率為29.77%,存活時間中位數(shù)為1.02年。男性患者存活時間顯著低于女性(χ2=212.29,P0.001)。支氣管及肺癌發(fā)病率位居惡性腫瘤發(fā)病第一位,存活時間中位數(shù)僅為0.76年。結(jié)論大豐區(qū)惡性腫瘤總體生存率較低,女性特殊腫瘤生存率相對較高,男性癌癥患者存活時間低于女性。
[Abstract]:The new cases of primary malignant tumor from 2008 to 2014 in Dafeng District of Yancheng City Jiangsu Province were followed up and the survival status of patients with malignant tumor was analyzed. Methods A total of 15 734 patients with primary malignant tumor were selected from January 1, 2008 to December 31, 2014 in Dafeng district. The follow-up period was from January 1, 2008 to January 7, 2016. The cumulative survival rate and median survival time were analyzed by life table method. Wilcoxon method was used to compare the difference of survival time between sexes. Results from 2008 to 2014, the incidence of malignant tumor was 310.54 / 100 000, and the standardized rate was 179.96% / 100,000. The 5-year cumulative survival rate was 29.77 and the median survival time was 1.02 years. The survival time of male patients was significantly lower than that of females (蠂 2 212.29 P 0.001). The incidence of bronchus and lung cancer was the first in malignant tumors, and the median survival time was only 0.76 years. Conclusion the overall survival rate of malignant tumors in Dafeng district is lower than that of women with special tumors, and the survival time of male cancer patients is lower than that of women.
【作者單位】： 大豐市疾病預(yù)防控制中心慢病科;江蘇省疾病預(yù)防控制中心慢病所;
【基金】：江蘇省衛(wèi)生計生委預(yù)防醫(yī)學(xué)科研課題(Y2015058)
【分類號】：R73-31
，

本文編號：2084180